BioPharma Drive: Drug Pricing

JUNE 18, 2024

Belharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere, Regenxbio mapped a regulatory path and Taysha shared updated results for its Rett treatment.

Drug Research 70

Drug Research Research Drugs Treatment 70

BioPharma Drive: Drug Pricing

SEPTEMBER 7, 2023

The Series B round makes Mariana one of the best funded private companies in a growing group of biotechs working on new radiopharmaceutical therapies.

Drug Research 70

Drug Research Research Therapies Drugs 70

BioPharma Drive: Drug Pricing

JULY 11, 2023

RA Capital led a Series B financing round that drew participation from more than a dozen blue-chip venture backers, including new investors Goldman Sachs and Vertex Ventures.

Drug Research 44

Drug Research Research Drugs 44

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

BioPharma Drive: Drug Pricing

JANUARY 12, 2024

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

Drug Research 130

Drug Research Research Drugs 130

BioPharma Drive: Drug Pricing

DECEMBER 7, 2023

The funding is indicative of investor interest in an area of drug research that involves at least a dozen startups and multiple publicly traded companies.

Drug Research 133

Drug Research Research Drugs 133

BioPharma Drive: Drug Pricing

AUGUST 16, 2024

Some industry watchers described the level of price discounts announced by Medicare as a "relief," though they warned of bigger future implications for drug research.

Drugs 73

Drugs Drug Research Research 73

BioPharma Drive: Drug Pricing

DECEMBER 13, 2023

The company is now expecting to save $4 billion by the end of 2024, with a majority of the spending cuts coming from drug research and development.

Drug Research 117

Drug Research Research Drugs 117

Chemical Biology and Drug Design

JULY 5, 2024

Abstract Intestinal absorption of compounds is significant in drug research and development. The QSPR model accurately predicted the intestinal absorption of molecules, and the computer simulation found the mechanism of molecular structure affecting intestinal absorption.

Drug Research 100

Drug Research Research Drugs 100

Drugs.com

OCTOBER 24, 2023

23, 2023 -- New research suggests a link between middle school students being disciplined for marijuana use and legalization of recreational weed, particularly when schools are close to dispensaries that sell the drug. Researchers. MONDAY, Oct.

Drugs 110

Drugs Drug Research Research 110

BioPharma Drive: Drug Pricing

JULY 5, 2023

The deal enables Sarepta to quickly cash in on the clearance of Elevidys, with $102 million in new funds to help bankroll its drug research.

Therapies 108

Therapies FDA Drug Research Research 108

BioPharma Drive: Drug Pricing

AUGUST 15, 2023

More than a dozen startups have joined a few publicly traded biotechs and larger pharmaceutical firms in what’s become one of the most competitive areas in drug research.

Drug Research 98

Drug Research Pharmaceuticals Research Drugs 98

BioPharma Drive: Drug Pricing

MARCH 12, 2024

Allogene’s partnership with Arbor is designed to help the company stand out in what’s quickly become one of the industry’s hottest areas of drug research.

Therapies 73

Therapies Disease Drug Research Research 73

BioPharma Drive: Drug Pricing

FEBRUARY 28, 2024

Well-known scientist and biotech entrepreneur Robert Langer is helping Lindus Health address longstanding challenges in contract drug research.

Drug Research 62

Drug Research Research Drugs 62

Cytel

JUNE 19, 2024

Historically, many drugs have been prescribed to children even though this patient population have largely been excluded from clinical trials. There is an obvious logic. If medicines are to be used in children, they need to be studied in pediatric populations to ensure they are safe and effective.

Clinical Trials 59

Clinical Trials Regulations Drug Research Pharmaceuticals 59

BioPharma Drive: Drug Pricing

JUNE 14, 2023

The alliance is Astellas’ second recent partnership involving protein degraders, an emerging area of drug research the company has made a focus in recent years.

Drugs 70

Drugs Drug Research Research 70

DrugBank

AUGUST 20, 2024

The world of drug discovery is in a state of transformation, with advancements in biotechnology opening doors to new possibilities for targeting previously "undruggable" disease mechanisms. The Power of Drug Repurposing Explore the immense potential of drug repurposing as a strategy for targeting undruggable targets.

Therapies 71

Therapies Pharmaceuticals Disease Research 71

BioPharma Drive: Drug Pricing

JULY 6, 2023

The contract services provider, which secured the deal through a reportedly competitive process, expects CorEvitas to expand its drug research business.

Drug Research 52

Drug Research Research Drugs 52

DrugBank

SEPTEMBER 12, 2024

At DrugBank we’re committed to improving your daily research and drug development operations. It’s designed to fit naturally into your existing processes, enhancing your ability to collaborate with standardized definitions and focus on your research tasks.

Production 77

Production Government Packaging Research 77

Sygnature Discovery

SEPTEMBER 14, 2023

Sygnature Discovery is delighted to announce that its customer, River BioMedics , has raised an additional €2M in seed funding to continue its life-saving cardiovascular drug research. The biotech’s aim is to develop medicines that treat the underlying cause of heart failure rather than merely treating the symptoms.

Small Molecule 52

Small Molecule Assay Development Disease Drug Research 52

BioPharma Drive: Drug Pricing

JULY 26, 2023

The startup, which initially aims to make cancer medicines, claims to have a new twist on covalent drug research.

Drugs 52

Drugs Drug Research Research 52

Drug Target Review

APRIL 17, 2023

Featured within this ebook are in-depth application notes as well as the latest research from leading academics and pharmaceutical companies, including: Anders Bach, Associate Professor at the Department of Drug Design and Pharmacology at the University of Copenhagen Researchers from the Francis Crick Institute and GlaxoSmithKline , Dr Andrew Powell, (..)

Pharmaceutical Companies 52

Pharmaceutical Companies Laboratories Drugs Drug Research 52

Drug Channels

MARCH 5, 2024

The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Pharmacies and Pharmacy Benefit Managers. Read on for full details on pricing and registration.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Drug Target Review

OCTOBER 26, 2023

Alipogene tiparvovec and voretigene neparvovec-rzyl, two recombinant AAV-based gene therapy products, were approved by the European Medicines Agency (EMA) to treat lipoprotein lipase deficiency in 2012 2 and by the US Food and Drug Administration (FDA) to treat inherited retinal dystrophy in 2017, respectively.

Engineering 105

Engineering Virus Therapies Immune Response 105

Drug Target Review

SEPTEMBER 21, 2023

Introduction I clearly remember an incident as a researcher, which kept happening, from my undergraduate research up till now. Summary of research The undergraduate study concentrated on the potential adulticidal effects of oral analgesics (acetaminophen, aspirin, and ibuprofen) on Onchocerca volvulus. doi: 10.1002/14651858.CD011146.pub2.

Drugs 106

Drugs Treatment Disease Research 106

DrugBank

MAY 15, 2024

The Evolution of Drug Discovery: From Dark Rooms to Precision Targets In the past, drug discovery often felt like a lucky guess. Researchers would sift through natural extracts , hoping to stumble upon a compound that exhibited beneficial effects. In fact, it's one of the most exciting areas in drug research today.

Small Molecule 81

Small Molecule Molecular Biology Drugs Disease 81

Crown Bioscience

AUGUST 2, 2021

Continue reading to learn more about IMIDs and some of the challenges facing the field, and to review some in vivo preclinical models that can be used to guide IMID drug research and development.

Disease 52

Disease Drug Development Immune Response Drugs 52

DrugBank

MARCH 22, 2024

There are many obstacles that you have to overcome on the road to success in early-stage drug discovery and drug repurposing research. As a result, the industry is turning to managed data sources and are having to weigh the costs and benefits of open data sources versus enterprise research tools.

Licensing 73

Licensing Licensing Research Production 73

ACTO

SEPTEMBER 11, 2024

“The life sciences industry is actively looking for new ways to leverage AI to bring drugs to market faster to patients waiting in need,” said Parth Khanna, CEO of ACTO. Current solutions are almost exclusively focused on marketing, HCP targeting, workflow automation, and performance insight.

Science 52

Science Pharma Companies Production Marketing 52

Advarra

AUGUST 16, 2022

Orphan drugs have historically faced a number of barriers, such as limited research and development (R&D) investment due to an expected lack of profitability as well as challenges in clinical trial design and recruitment. Before 1983, only 38 orphan drugs had received U.S. These centers, in conjunction with the FDA and U.S.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

Conversations in Drug Development Trends

FEBRUARY 21, 2024

As a result, we ensure collection of all urine and fecal samples over a period ranging between five to seven days, modifying the participant diet if needed.

Clinical Trials 80

Clinical Trials Pharmacy Clinical Pharmacology FDA 80

The Pharma Data

MAY 19, 2023

Yancopoulos Innovator Award , named in honor of the pioneering drug researcher and Regeneron co-founder, President and Chief Scientific Officer, for finding an efficient way to identify certain exoplanets that orbit very closely around their stars. Using her research, she says she found the smallest of these planets ever discovered.

Engineering 52

Engineering International Science Virus 52

Agency IQ

JUNE 7, 2024

FDA’s new guidance explains what to do during a BIMO inspection Under the FDA’s Bioresearch Monitoring (BIMO) program, the agency oversees the operation of regulated research. In short, the BIMO program oversees regulated research – both human and animal – in a variety of ways.

FDA 40

FDA Compliance Regulations Laboratories 40

Codon

JANUARY 21, 2024

When a vaccine fails, that can have downstream effects on how other researchers in the field approach their own vaccine development, and how funding gets moved around. If a Shigella vaccine fails, researchers save a lot of money by not testing it in the field and having it fail there. But it's hard to find the counterfactual.

Vaccine 111

Vaccine Trials Disease Treatment 111

NIH Director's Blog: Drug Development

FEBRUARY 16, 2021

These include drugs that you may have heard about on the news: remdesivir (an antiviral), dexamethasone (a steroid), and monoclonal antibodies from the companies Eli Lilly and Regeneron. Therapeutics Clinical Working Group : Prioritizes therapeutic agents for testing within an adaptive master protocol strategy for clinical research.

Clinical Trials 52

Clinical Trials Trials Hospitals Vaccine 52

The Pharma Data

NOVEMBER 10, 2020

Dr. Liu shared his over 30 years of R&D experience in drug development both in the global pharmaceutical companies and world renowned scientific research institutions. Yong-Jun Liu , the newly appointed President of Innovent also made his first public appearance on the virtual R&D day.

Biosimilars 52

Biosimilars Clinical Trials International Clinical Development 52

Agency IQ

AUGUST 2, 2024

(ACT EU) / Clinical Trials Coordination Groups (CTCG) 9/11/2024 9/11/2024 Public launch event on the guideline on good pharmacovigilance practices Module XVI on risk minimization measures and its Addendum II Webinar ( OPEN ) EMA 9/12/2024 9/12/2024 ENVI meeting Committee meeting ( OPEN ) Environment, Public Health and Food Safety (ENVI) 9/13/2024 9/13/2024 (..)

Regulations 40

Regulations Clinical Trials Production International 40